DM Intelligence

Guangzhou DM Intelligence Ltd. is a technology-oriented joint venture that applies deep learning to new drug discovery and design. The company's AI-based new drug screening platform is built on the QSAR model, powered by a deep learning framework, and optimized through training with marketed drugs. By efficiently utilizing supercomputing platforms, the company performs virtual compound molecular docking for specific targets within its proprietary database of millions of compounds, initially screening out a dataset of candidate substances.The company’s team mainly consists of senior biomedical experts, chemistry experts, senior artificial intelligence engineers, medical advisors from tertiary hospitals, and business management professionals. Its service scope covers stages from drug discovery, synthesis, optimization to preclinical validation, systematically and comprehensively increasing the success rate of new drug development while reducing overall R&D costs.